ÖZBİLÜM ŞAHİN, N. Et Al. 2013. The Role of NF-kappa B1A Promoter Polymorphisms on Coronary Artery Disease Risk. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.113, no.3 , 187-192.

ÖZBİLÜM ŞAHİN, N., ARSLAN, S., BERKAN, Ö., Yanartas, M., & AYDEMİR, E. I., (2013). The Role of NF-kappa B1A Promoter Polymorphisms on Coronary Artery Disease Risk. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.113, no.3, 187-192.

ÖZBİLÜM ŞAHİN, NİL Et Al. "The Role of NF-kappa B1A Promoter Polymorphisms on Coronary Artery Disease Risk," BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.113, no.3, 187-192, 2013

ÖZBİLÜM ŞAHİN, NİL Ö. Et Al. "The Role of NF-kappa B1A Promoter Polymorphisms on Coronary Artery Disease Risk." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.113, no.3, pp.187-192, 2013

ÖZBİLÜM ŞAHİN, N. Et Al. (2013) . "The Role of NF-kappa B1A Promoter Polymorphisms on Coronary Artery Disease Risk." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.113, no.3, pp.187-192.

@article{article, author={NİL ÖZBİLÜM ŞAHİN Et Al. }, title={The Role of NF-kappa B1A Promoter Polymorphisms on Coronary Artery Disease Risk}, journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY}, year=2013, pages={187-192} }